...
search icon
mynz-img

Mainz Biomed BV Share Price

MYNZ
NAQ
$0.6237
-$0.05
(-7.4%)
1D
Industry: Biotechnology Sector: Health Care

Mainz Biomed BV Analyst Forecast

Mainz Biomed BV Share Price Chart

Mainz Biomed BV Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.12M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
352.85K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.26
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.6 L
$6.29 H
$0.6237

About Mainz Biomed BV, Common Stock

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany. more

Industry: BiotechnologySector: Health Care

Mainz Biomed BV Stock Returns

Time FrameMYNZSectorS&P500
1-Week Return-26.35%0.72%-1.31%
1-Month Return-43.3%1.27%0.78%
3-Month Return-48.02%3.13%3.46%
6-Month Return-65.35%15.81%6.19%
1-Year Return-89.6%8.89%11.68%
3-Year Return-99.78%20.79%71.21%
5-Year Return-99.84%35.89%74.81%

Mainz Biomed BV Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue493.56K577.35K529.88K895.48K893.99K[{"date":"2020-12-31","value":55.12,"profit":true},{"date":"2021-12-31","value":64.47,"profit":true},{"date":"2022-12-31","value":59.17,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.83,"profit":true}]
Cost of Revenue370.48K399.73K347.73K385.82K319.11K[{"date":"2020-12-31","value":92.68,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.99,"profit":true},{"date":"2023-12-31","value":96.52,"profit":true},{"date":"2024-12-31","value":79.83,"profit":true}]
Gross Profit123.08K177.62K182.15K509.66K574.88K[{"date":"2020-12-31","value":21.41,"profit":true},{"date":"2021-12-31","value":30.9,"profit":true},{"date":"2022-12-31","value":31.68,"profit":true},{"date":"2023-12-31","value":88.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin24.94%30.77%34.38%56.91%64.31%[{"date":"2020-12-31","value":38.78,"profit":true},{"date":"2021-12-31","value":47.84,"profit":true},{"date":"2022-12-31","value":53.46,"profit":true},{"date":"2023-12-31","value":88.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses796.80K9.56M26.36M27.15M19.27M[{"date":"2020-12-31","value":2.93,"profit":true},{"date":"2021-12-31","value":35.19,"profit":true},{"date":"2022-12-31","value":97.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":70.97,"profit":true}]
Operating Income(766.09K)(9.72M)(26.44M)(26.64M)(18.70M)[{"date":"2020-12-31","value":-76609000,"profit":false},{"date":"2021-12-31","value":-972460600,"profit":false},{"date":"2022-12-31","value":-2644404000,"profit":false},{"date":"2023-12-31","value":-2664468200,"profit":false},{"date":"2024-12-31","value":-1869540800,"profit":false}]
Total Non-Operating Income/Expense(181.97K)(2.30M)(232.62K)(460.63K)(4.03M)[{"date":"2020-12-31","value":-18197200,"profit":false},{"date":"2021-12-31","value":-230466300,"profit":false},{"date":"2022-12-31","value":-23262000,"profit":false},{"date":"2023-12-31","value":-46062600,"profit":false},{"date":"2024-12-31","value":-403048700,"profit":false}]
Pre-Tax Income(586.89K)(11.70M)(26.39M)(26.30M)(21.65M)[{"date":"2020-12-31","value":-58689500,"profit":false},{"date":"2021-12-31","value":-1169515800,"profit":false},{"date":"2022-12-31","value":-2638733600,"profit":false},{"date":"2023-12-31","value":-2629572700,"profit":false},{"date":"2024-12-31","value":-2165066300,"profit":false}]
Income Taxes299.28K377.12K65.39K1.92M-[{"date":"2020-12-31","value":15.59,"profit":true},{"date":"2021-12-31","value":19.65,"profit":true},{"date":"2022-12-31","value":3.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(886.18K)(12.07M)(26.45M)(28.22M)-[{"date":"2020-12-31","value":-88617700,"profit":false},{"date":"2021-12-31","value":-1207228000,"profit":false},{"date":"2022-12-31","value":-2645272500,"profit":false},{"date":"2023-12-31","value":-2821516700,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(586.89K)(11.70M)(26.39M)(26.30M)(21.65M)[{"date":"2020-12-31","value":-58689500,"profit":false},{"date":"2021-12-31","value":-1169515800,"profit":false},{"date":"2022-12-31","value":-2638733600,"profit":false},{"date":"2023-12-31","value":-2629572700,"profit":false},{"date":"2024-12-31","value":-2165066300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(586.89K)(11.69M)(26.45M)(26.30M)(21.65M)[{"date":"2020-12-31","value":-58689500,"profit":false},{"date":"2021-12-31","value":-1169009800,"profit":false},{"date":"2022-12-31","value":-2645272500,"profit":false},{"date":"2023-12-31","value":-2629572700,"profit":false},{"date":"2024-12-31","value":-2165066300,"profit":false}]
EPS (Diluted)-(0.17)(2.19)(1.64)(27.55)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-16.98,"profit":false},{"date":"2022-12-31","value":-219,"profit":false},{"date":"2023-12-31","value":-164,"profit":false},{"date":"2024-12-31","value":-2755,"profit":false}]

Mainz Biomed BV Ratios

Mainz Biomed BV Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

MYNZ
Cash Ratio 0.32
Current Ratio 0.52
Quick Ratio 0.43

Mainz Biomed BV Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MYNZ
ROA (LTM) -114.35%
ROE (LTM) -465.82%

Mainz Biomed BV Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MYNZ
Debt Ratio Lower is generally better. Negative is bad. 0.74
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.26

Mainz Biomed BV Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MYNZ
Trailing PE NM
Forward PE NM
P/S (TTM) 9.27
P/B 2.87
Price/FCF NM
EV/R 12.78
EV/Ebitda NM

FAQs

What is Mainz Biomed BV share price today?

Mainz Biomed BV (MYNZ) share price today is $0.6237

Can Indians buy Mainz Biomed BV shares?

Yes, Indians can buy shares of Mainz Biomed BV (MYNZ) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MYNZ stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Mainz Biomed BV be purchased?

Yes, you can purchase fractional shares of Mainz Biomed BV (MYNZ) via the Vested app. You can start investing in Mainz Biomed BV (MYNZ) with a minimum investment of $1.

How to invest in Mainz Biomed BV shares from India?

You can invest in shares of Mainz Biomed BV (MYNZ) via Vested in three simple steps:

  • Click on Sign Up or Invest in MYNZ stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Mainz Biomed BV shares
What is Mainz Biomed BV 52-week high and low stock price?

The 52-week high price of Mainz Biomed BV (MYNZ) is $6.29. The 52-week low price of Mainz Biomed BV (MYNZ) is $0.6.

What is Mainz Biomed BV price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Mainz Biomed BV (MYNZ) is

What is Mainz Biomed BV price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Mainz Biomed BV (MYNZ) is 2.87

What is Mainz Biomed BV dividend yield?

The dividend yield of Mainz Biomed BV (MYNZ) is 0.00%

What is the Market Cap of Mainz Biomed BV?

The market capitalization of Mainz Biomed BV (MYNZ) is $6.12M

What is Mainz Biomed BV's stock symbol?

The stock symbol (or ticker) of Mainz Biomed BV is MYNZ

How Can Investors Use Mainz Biomed BV Share Price Data for Long-Term Investment Decisions?

Consider the share price of Mainz Biomed BV as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Mainz Biomed BV has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Mainz Biomed BV shares for Indian investors?

When investing in Mainz Biomed BV shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Mainz Biomed BV stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Mainz Biomed BV share price with other stocks in the same sector?

Rather than merely checking the share price of Mainz Biomed BV and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Mainz Biomed BV stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top